Adjuvant therapy in renal cell carcinoma-is pharmacogenomics assessment another element to select our patients?

Ann Transl Med. 2019 Mar;7(Suppl 1):S38. doi: 10.21037/atm.2019.02.31.
No abstract available

Publication types

  • Editorial
  • Comment